This Article Full Text Full Text (PDF) All Versions of this Article: 35/7/1715    most recent 01.STR.0000129334.05181.b6v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lee, C. Z. Articles by Young, W. L. Search for Related Content PubMed PubMed Citation Articles by Lee, C. Z. Articles by Young, W. L. Related Collections Angiogenesis Animal models of human disease Growth factors/cytokines Other Stroke Treatment - Medical Gene therapy Other Vascular biology

(Stroke. 2004;35:1715.)
© 2004 American Heart Association, Inc.

Original Contributions

Doxycycline Suppresses Cerebral Matrix Metalloproteinase-9 and Angiogenesis Induced by Focal Hyperstimulation of Vascular Endothelial Growth Factor in a Mouse Model

Chanhung Z. Lee, MD, PhD; Bin Xu, MD; Tomoki Hashimoto, MD; Charles E. McCulloch, PhD; Guo-Yuan Yang, MD, PhD William L. Young, MD

From the Departments of Anesthesia and Perioperative Care (C.Z.L., B.X., T.H., G.-Y.Y., W.L.Y.), Epidemiology and Biostatistics (C.E.M.), Neurological Surgery (G.-Y.Y., W.L.Y.), and Neurology (W.L.Y.), and the Center for Cerebrovascular Research (C.Z.L., B.X., T.H., G.-Y.Y., W.L.Y.), University of California, San Francisco.

Correspondence to Dr William L. Young, Center for Cerebrovascular Research, 1001 Potrero Ave, Room 3C-38, San Francisco, CA 94110. E-mail ccr{at}anesthesia.ucsf.edu

Background and Purpose— A number of central nervous system (CNS) disorders are associated with abnormalities in or activation of angiogenesis, including vascular malformations. To test the hypothesis that the nonspecific matrix metalloproteinase (MMP) inhibitor, doxycycline, suppresses vascular endothelial growth factor (VEGF)-induced cerebral angiogenesis through inhibition of MMPs, we used a mouse model with enhanced cerebral angiogenesis induced by focal hyperstimulation of VEGF from adenovirus DNA (AdVEGF) transduction.

Methods— The time course study of MMP activity was performed at 7 and 14 days after AdVEGF transduction. MMP activity and expression were examined by zymography and immunohistochemistry, respectively. As an index of cerebral angiogenesis, microvessel counting was performed in the brains of 3 groups of mice (n=6): (1) control; (2) AdVEGF only; and (3) AdVEGF plus doxycycline (30 mg/kg per day).

Results— Brain MMP-9 activities increased 4-fold (883±137 versus 179±179; 1-sided P<0.001) at 7 days after AdVEGF transduction. VEGF transduction increased vessel counts by 19% (255±27 versus 215±15, 1-sided P<0.01). Doxycycline treatment decreased MMP-9 activity (89±72 versus 883±137; 1-sided P<0.001) and cerebral microvessel number (231±17 versus 255±27; 1-sided P<0.05).

Conclusions— Doxycycline is effective in decreasing stimulated cerebral MMP-9 activity and parenchymal angiogenesis. The decrease in MMP-9 activity is associated with decreased microvessel counts. Brain pathophysiological processes that involve abnormally enhanced angiogenesis may be amenable to manipulation by MMP inhibitors, including tetracycline derivatives.

Key Words: drug therapy • metalloproteinases • angiogenesis

This article has been cited by other articles:

				P. A. Murphy, M. T. Y. Lam, X. Wu, T. N. Kim, S. M. Vartanian, A. W. Bollen, T. R. Carlson, and R. A. Wang Endothelial Notch4 signaling induces hallmarks of brain arteriovenous malformations in mice PNAS, August 5, 2008; 105(31): 10901 - 10906. [Abstract] [Full Text] [PDF]

				N. Matsunaga, Y. Chikaraishi, M. Shimazawa, S. Yokota, and H. Hara Vaccinium myrtillus (Bilberry) Extracts Reduce Angiogenesis In Vitro and In Vivo Evid. Based Complement. Altern. Med., October 27, 2007; (2007) nem151v1. [Abstract] [Full Text] [PDF]

				T. L. Haas, J. L. Doyle, M. R. Distasi, L. E. Norton, K. M. Sheridan, and J. L. Unthank Involvement of MMPs in the outward remodeling of collateral mesenteric arteries Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2429 - H2437. [Abstract] [Full Text] [PDF]

				C. Z. Lee, Z. Xue, Y. Zhu, G.-Y. Yang, and W. L. Young Matrix Metalloproteinase-9 Inhibition Attenuates Vascular Endothelial Growth Factor-Induced Intracerebral Hemorrhage Stroke, September 1, 2007; 38(9): 2563 - 2568. [Abstract] [Full Text] [PDF]

				H. Petkovic, J. Cullum, D. Hranueli, I. S. Hunter, N. Peric-Concha, J. Pigac, A. Thamchaipenet, D. Vujaklija, and P. F. Long Genetics of Streptomyces rimosus, the Oxytetracycline Producer Microbiol. Mol. Biol. Rev., September 1, 2006; 70(3): 704 - 728. [Abstract] [Full Text] [PDF]

				D. N. Meli, R. S. Coimbra, D. G. Erhart, G. Loquet, C. L. Bellac, M. G. Tauber, U. Neumann, and S. L. Leib Doxycycline Reduces Mortality and Injury to the Brain and Cochlea in Experimental Pneumococcal Meningitis Infect. Immun., July 1, 2006; 74(7): 3890 - 3896. [Abstract] [Full Text] [PDF]

				I. Cardoso and M. J. Saraiva Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model FASEB J, February 1, 2006; 20(2): 234 - 239. [Abstract] [Full Text] [PDF]

				Y. Zhu, C. Lee, F. Shen, R. Du, W. L. Young, and G.-Y. Yang Angiopoietin-2 Facilitates Vascular Endothelial Growth Factor-Induced Angiogenesis in the Mature Mouse Brain Stroke, July 1, 2005; 36(7): 1533 - 1537. [Abstract] [Full Text] [PDF]